avapritinib, kit d816v (Mastocytosis Society)
Structured Review
Avapritinib, Kit D816v, supplied by Mastocytosis Society, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d816v+kit/kit+d816v/pmc11996035-5-2-4
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Systemic Mastocytosis: Current Status and Challenges in 2024. Article Snippet: Wilson TM, Maric I, Simakova O, et al. Clonal analysis of NRAS activating mutations in Article Title: Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth Article Snippet: On the other hand, KIT signaling can enhance Article Title: Avapritinib for Systemic Mastocytosis Article Snippet: Avapritinib, kit d816v, Article Title: Mastocytosis. Article Snippet: Mastocytosis is a spectrum of clonal myeloid disorders defined by abnormal growth and accumulation of mast cells in various organ systems.. The disease is divided into cutaneous mastocytosis, systemic mastocytosis (SM) and mast cell sarcoma.. SM is further categorized into several non-advanced and advanced forms. Mutagenesis:Article Title: Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications Article Snippet: .. Furthermore, systemic mastocytosis (SM), a rare condition, is characterized by a KIT Article Title: Current and future therapeutics targeting mast cells in disease. Article Snippet: Mast cells (MCs) are tissue resident immune cells which are best known for their detrimental role in allergy.. Increasing evidence indicates that MCs are also central to the pathogenesis of chronic urticaria.. Abnormal increase in MC burden, in most cases driven by gain-of-function mutations in the receptor KIT, can also lead to mastocytosis, a potentially severe malignant disease. Variant Assay:Article Title: Childhood mastocytosis: challenges and potential shortfalls in current disease classification. Article Snippet: 16 17 The skin is the organ most frequently involved in childhood mastocytosis.. In this article, we present 18 a comprehensive update on recent relevant data in the field of childhood mastocytosis, and critically 19 review the drawbacks of its current classification and skin manifestations.. We hypothesize that two 20 main types of childhood mastocytosis can be recognized, with relevant implications for the outcome, 21 management and understanding of the disease. Diagnostic Assay:Article Title: Childhood mastocytosis: challenges and potential shortfalls in current disease classification. Article Snippet: 16 17 The skin is the organ most frequently involved in childhood mastocytosis.. In this article, we present 18 a comprehensive update on recent relevant data in the field of childhood mastocytosis, and critically 19 review the drawbacks of its current classification and skin manifestations.. We hypothesize that two 20 main types of childhood mastocytosis can be recognized, with relevant implications for the outcome, 21 management and understanding of the disease. |
